Allakos Future Growth
Future criteria checks 0/6
Allakos is forecast to grow earnings and revenue by 31.9% and 67.8% per annum respectively while EPS is expected to grow by 42.4% per annum.
Key information
31.9%
Earnings growth rate
42.4%
EPS growth rate
| Biotechs earnings growth | 26.8% |
| Revenue growth rate | 67.8% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 17 Dec 2024 |
Recent future growth updates
Recent updates
Allakos Runs Up Into A Near-Term Catalyst
Nov 07We Think Allakos (NASDAQ:ALLK) Needs To Drive Business Growth Carefully
Aug 27
We're Keeping An Eye On Allakos' (NASDAQ:ALLK) Cash Burn Rate
May 05We're Keeping An Eye On Allakos' (NASDAQ:ALLK) Cash Burn Rate
Dec 01Companies Like Allakos (NASDAQ:ALLK) Are In A Position To Invest In Growth
Aug 03Allakos (NASDAQ:ALLK) Will Have To Spend Its Cash Wisely
Apr 20Is Allakos Inc. (NASDAQ:ALLK) Expensive For A Reason? A Look At Its Intrinsic Value
Jan 04Allakos: Potential For Comeback With Lirentelimab With 2 Indications
Oct 18Allakos prices ~$150M underwritten offering
Sep 19Allakos falls as lead asset offers mixed results in late-stage trial
Sep 09Allakos (NASDAQ:ALLK) Will Have To Spend Its Cash Wisely
Aug 06Will Allakos (NASDAQ:ALLK) Spend Its Cash Wisely?
Apr 22Allakos: Sad End To A Promising Asset
Dec 23We're Hopeful That Allakos (NASDAQ:ALLK) Will Use Its Cash Wisely
Dec 01We Think Allakos (NASDAQ:ALLK) Can Afford To Drive Business Growth
Aug 16Allakos: Upcoming Phase 3 Data Makes The Stock Interesting
Aug 06Allakos provides lirentelimab clinical trial enrollment updates, names new CMO
Jun 07We're Hopeful That Allakos (NASDAQ:ALLK) Will Use Its Cash Wisely
May 02Have Allakos Inc. (NASDAQ:ALLK) Insiders Been Selling Their Stock?
Mar 10Allakos Inc. (NASDAQ:ALLK) Insiders Have Been Selling
Jan 28
We're Interested To See How Allakos (NASDAQ:ALLK) Uses Its Cash Hoard To Grow
Dec 07Allakos EPS misses by $0.02
Nov 09Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2027 | N/A | -115 | N/A | -87 | 4 |
| 12/31/2026 | N/A | -85 | N/A | -67 | 4 |
| 12/31/2025 | N/A | -66 | N/A | -20 | 5 |
| 12/31/2024 | N/A | -130 | N/A | -42 | 5 |
| 9/30/2024 | N/A | -179 | -105 | -105 | N/A |
| 6/30/2024 | N/A | -206 | -103 | -103 | N/A |
| 3/31/2024 | N/A | -214 | -119 | -119 | N/A |
| 12/31/2023 | N/A | -186 | -117 | -116 | N/A |
| 9/30/2023 | N/A | -166 | -140 | -139 | N/A |
| 6/30/2023 | N/A | -151 | -139 | -136 | N/A |
| 3/31/2023 | N/A | -165 | -142 | -136 | N/A |
| 12/31/2022 | N/A | -320 | -288 | -280 | N/A |
| 9/30/2022 | N/A | -371 | -322 | -299 | N/A |
| 6/30/2022 | N/A | -403 | -350 | -319 | N/A |
| 3/31/2022 | N/A | -411 | -371 | -336 | N/A |
| 12/31/2021 | N/A | -270 | -241 | -208 | N/A |
| 9/30/2021 | N/A | -220 | -195 | -177 | N/A |
| 6/30/2021 | N/A | -199 | -174 | -166 | N/A |
| 3/31/2021 | N/A | -181 | -143 | -142 | N/A |
| 12/31/2020 | N/A | -153 | -115 | -114 | N/A |
| 9/30/2020 | N/A | -134 | -99 | -99 | N/A |
| 6/30/2020 | N/A | -113 | -79 | -79 | N/A |
| 3/31/2020 | N/A | -93 | -69 | -68 | N/A |
| 12/31/2019 | N/A | -85 | -64 | -63 | N/A |
| 9/30/2019 | N/A | -75 | -60 | -57 | N/A |
| 6/30/2019 | N/A | -65 | -55 | -49 | N/A |
| 3/31/2019 | N/A | -55 | -49 | -42 | N/A |
| 12/31/2018 | N/A | -44 | -45 | -38 | N/A |
| 9/30/2018 | N/A | -37 | -38 | -33 | N/A |
| 6/30/2018 | N/A | -32 | N/A | -30 | N/A |
| 3/31/2018 | N/A | -27 | N/A | -26 | N/A |
| 12/31/2017 | N/A | -24 | N/A | -23 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ALLK is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ALLK is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ALLK is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ALLK is forecast to have no revenue next year.
High Growth Revenue: ALLK is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ALLK's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 14:24 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Allakos Inc. is covered by 11 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Carter Gould | Barclays |
| Jason Zemansky | BofA Global Research |
| Jennifer Kim | Cantor Fitzgerald & Co. |